Patents by Inventor Ernst Buschmann
Ernst Buschmann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 8440626Abstract: The present invention provides antineoplastic peptides of formula I, I R1R2N-CHX-CO-A-B-D-E-(G)S-K wherein R1, R2, X, A, B, D, E, G, K and s have the meanings stated in the description. The compounds have antineoplastic activity.Type: GrantFiled: August 26, 2010Date of Patent: May 14, 2013Assignee: Abbott GmbH & Co. KGInventors: Wilhelm Amberg, Teresa Barlozzari, Harald Bernard, Ernst Buschmann, Andreas Haupt, Hans-Guenther Hege, Bernd Janssen, Andreas Kling, Helmut Lietz, Kurt Ritter, Martina Ullrich, Jurgen Weymann, Thomas Zierke
-
Publication number: 20110098235Abstract: The present invention provides antineoplastic peptides of formula I, R1R2N-CHX-CO-A-B-D-E-(G)S-K?I wherein R1, R2, X, A, B, D, G, K and s have the meanings stated in the description. The compounds have antineoplastic activity.Type: ApplicationFiled: August 26, 2010Publication date: April 28, 2011Applicant: ABBOTT GMBH & CO. KGInventors: Wilhelm AMBERG, Teresa BARLOZZARI, Harald BERNARD, Ernst BUSCHMANN, Andreas HAUPT, Hans-Guenther HEGE, Bernd JANSSEN, Andreas KLING, Helmut LIETZ, Kurt RITTER, Martina ULLRICH, Jürgen WEYMANN, Thomas ZIERKE
-
Patent number: 7807779Abstract: The present invention provides antineoplastic peptides of formula I, R1R2N—CHX—CO—A—B-D-E-(G)s-K wherein R1, R2, X, A, B, D, E, G, K and s have the meanings stated in the description. The compounds have antineoplastic activity.Type: GrantFiled: March 31, 2008Date of Patent: October 5, 2010Assignee: Abbott GmbH & Co. KGInventors: Wilhelm Amberg, Teresa Barlozzari, Harald Bernard, Ernst Buschmann, Andreas Haupt, Hans-Guenther Hege, Bernd Janssen, Andreas Kling, Helmut Lietz, Kurt Ritter, Martina Ullrich, Jurgen Weymann, Thomas Zierke
-
Publication number: 20080234205Abstract: The present invention provides antineoplastic peptides of formula I, R1R2N—CHX—CO—A—B-D-E-(G)s-K wherein R1, R2, X, A, B, D, E, G, K and s have the meanings stated in the description. The compounds have antineoplastic activity.Type: ApplicationFiled: March 31, 2008Publication date: September 25, 2008Applicant: Abbott GmbH & Co. KGInventors: Wilhelm Amberg, Teresa Barlozzari, Harald Bernard, Ernst Buschmann, Andreas Haupt, Hans-Guenther Hege, Bernd Janssen, Andreas Kling, Helmut Lietz, Kurt Ritter, Martina Ullrich, Jurgen Weymann, Thomas Zierke
-
Patent number: 7368528Abstract: The present invention provides antineoplastic peptides of formula I, R1R2N—CHX—CO-A-B-D-E-(G)s-K I wherein R1, R2, X, A, B, D, E, G, K, and s have the meanings stated in the description. The compounds have antineoplastic activity.Type: GrantFiled: July 11, 2005Date of Patent: May 6, 2008Assignee: Abbott GmbH & Co. KGInventors: Wilhelm Amberg, Teresa Barlozzari, Harald Bernard, Ernst Buschmann, Andreas Haupt, Hans-Guenther Hege, Bernd Janssen, Andreas Kling, Helmut Lietz, Kurt Ritter, Martina Ullrich, Jurgen Weyman, Thomas Zierke
-
Publication number: 20060009392Abstract: The present invention provides antineoplastic peptides of formula I, R1R2N—CHX—CO-A-B-D-E-(G)s-K ??I wherein R1, R2, X, A, B, D, E, G, K, and s have the meanings stated in the description. The compounds have antineoplastic activity.Type: ApplicationFiled: July 11, 2005Publication date: January 12, 2006Applicant: Abbott GMBH & Co., KG.Inventors: Wilhelm Amberg, Teresa Barlozzari, Harald Bernard, Ernst Buschmann, Andreas Haupt, Hans-Guenther Hege, Bernd Janssen, Andreas Kling, Helmut Lietz, Kurt Ritter, Martina Ullrich, Jurgen Weymann, Thomas Zierke
-
Patent number: 6328855Abstract: A process for preparing (+)-exo-6-phenyl-3-azabicyclo[3.2.0]heptanes of the formula I where R is hydrogen, chlorine, bromine, fluorine or methoxy, which comprises photocyclizing a bisallylammonium salt of the formula II where R has the meanings given above and X− is an anion, in an inert solvent in a glass apparatus with addition of sensitizer and precipitating using (−)-ditoluoyltartaric acid the desired (+)-exo-isomer I as ditoluoyltartrate from the resulting mixture, with or without recrystallization of this tartrate from an alcohol/water mixture.Type: GrantFiled: April 11, 2001Date of Patent: December 11, 2001Assignee: BASF AktiengesellschaftInventors: Norbert Bischof, Ernst Buschmann, Michael Henningsen, Georg Arnold Krei, Rainer Munschauer, Thomas Pfeiffer, Gerd Steiner, Wolfgang Viergutz
-
Publication number: 20010009901Abstract: The present invention provides antineoplastic peptides of formula I,Type: ApplicationFiled: January 9, 2001Publication date: July 26, 2001Applicant: BASF Aktiengesellschaft GermanyInventors: Wilhelm Amberg, Teresa Barlozzari, Harald Bernard, Ernst Buschmann, Andreas Haupt, Hans-Guenther Hege, Bernd Janssen, Andreas Kling, Helmut Lietz, Kurt Ritter, Martina Ullrich, Jurgen Weymann, Thomas Zierke
-
Patent number: 6248865Abstract: Compounds of the formula where R1, R2, R3 and R4 have the meaning stated in the description, and a process for preparing them are described. The compounds are suitable as starting material for synthesizing substances which are active against tumors.Type: GrantFiled: December 15, 1998Date of Patent: June 19, 2001Assignee: BASF AktiengesellschaftInventors: Wilhelm Amberg, Harald Bernard, Ernst Buschmann, Andreas Haupt, Lothar Janitschke, Bernd Janssen, Ulrich Karl, Andreas Kling, Stefan Müller, Bernd de Potzolli, Kurt Ritter, Marco Thyes, Thomas Zierke
-
Patent number: 6211397Abstract: A process for the preparation of &agr;-chloromethylene-triorganylphosphorane derivatives I (radicals R are C-organic substituents and A stands for CN or CO-B where B is a C-organic or O-organic radical which is inert under chlorination conditions) by chlorination of phosphoranes II with chlorine, wherein the chlorination is carried out in the presence of a mineral base as hydrogen chloride acceptor and the chlorine and base are fed to the reaction mixture concurrently but separately at the rates at which they are consumed. The reaction products I are important intermediates for plant protectants.Type: GrantFiled: March 2, 1994Date of Patent: April 3, 2001Assignee: BASF AktiengesellschaftInventors: Bernd Schaefer, Ernst Buschmann, Gernot Reissenweber
-
Patent number: 5965700Abstract: A process for preparing pentapeptides of the formula I ##STR1## where A and R.sup.1 -R.sup.3 have the stated meanings, comprises assembling the pentapeptide stepwise starting from a prolinamide of the formula II ##STR2## where R.sup.1 and R.sup.2 have the abovementioned meanings, and eliminating the group --NR.sup.1 R.sup.2 by hydrolysis where appropriate the peptide obtained in this way.Type: GrantFiled: January 13, 1998Date of Patent: October 12, 1999Assignee: BASF AktiengesellschaftInventors: Wilhelm Amberg, Harald Bernard, Ernst Buschmann, Andreas Haupt, Bernd Janssen, Ulrich Karl, Andreas Kling, Stefan Muller, Kurt Ritter, Thomas Zierke
-
Patent number: 5945543Abstract: A process for preparing .alpha.-(N,N-dialkylamino) carboxamides of the formula I ##STR1## where the substituents have the stated meanings, comprises reacting the corresponding free acids with primary or secondary amines in the presence of anhydrides of an alkanephosphonic acid.Type: GrantFiled: January 20, 1998Date of Patent: August 31, 1999Assignee: BASF AktiengesellschaftInventors: Ernst Buschmann, Thomas Zierke
-
Patent number: 5886147Abstract: Compounds of the formula ##STR1## where R.sup.1, R.sup.2, R.sup.3 and R.sup.4 have the meaning stated in the description, and a process for preparing them are described. The compounds are suitable as starting material for synthesizing substances which are active against tumors.Type: GrantFiled: November 6, 1996Date of Patent: March 23, 1999Assignee: BASF AktiengesellschaftInventors: Wilhelm Amberg, Harald Bernard, Ernst Buschmann, Andreas Haupt, Lothar Janitschke, Bernd Janssen, Ulrich Karl, Andreas Kling, Stefan Muller, Bernd de Potzolli, Kurt Ritter, Marco Thyes, Thomas Zierke
-
Patent number: 5864012Abstract: The compound Me.sub.2 Val--Val--MeVal--Pro--Pro--NHBzl.multidot.HCl is described. It is prepared from Z--Val--Val--MeVal--Pro--OR.sup.1 where Z and R.sup.1 have the meanings stated in the description. The compound shows antineoplastic activity.Type: GrantFiled: November 4, 1996Date of Patent: January 26, 1999Assignee: BASF AktiengesellschaftInventors: Wilhelm Amberg, Harald Bernard, Ernst Buschmann, Andreas Haupt, Lothar Janitschke, Bernd Janssen, Ulrich Karl, Andreas Kling, Stefan Muller, Bernd de Potzolli, Kurt Ritter, Marco Thyes, Thomas Zierke
-
Patent number: 5807984Abstract: Novel peptides of the formulaA--B--D--E--F--L,wherein A, B, D, E, F, and L have the meanings stated in the specification, and their preparation are disclosed. The novel compounds are suitable for controlling diseases.Type: GrantFiled: November 9, 1995Date of Patent: September 15, 1998Assignee: BASF AktienegesellschaftInventors: Andreas Kling, Bernd Janssen, Wilhelm Amberg, Andreas Haupt, Kurt Ritter, Ernst Buschmann, Harald Bernard, Stefan Muller, Thomas Zierke, Teresa Barlozzari, Monika de Arruda, Simon Robinson
-
Patent number: 5599848Abstract: A process for preparing a mixture of 8E,10E-dodecadienol (Ia), 8E,10Z-dodecadienol (Ib), 8Z,10E-dodecadienol (Ic) and 8Z,10Z-dodecadienol (Id),H.sub.3 C--CH.dbd.CH--CH.dbd.CH--(CH.sub.2).sub.6 --CH.sub.2 --OH(8E,10E=Ia)(8E,10Z=Ib)(8Z,10E=Ic)(8Z,10Z=Id)starting from 1,8-octanediol (II) which is converted with a halogenating agent into (III)Hal-CH.sub.2 --(CH.sub.2).sub.6 --CH.sub.2 --OH (III)where (III) is subsequently reacted with (IV),H.sub.2 C.dbd.CH--O--R (IV)to give (V)Hal-CH.sub.2 --(CH.sub.2).sub.6 --CH.sub.2 --O--CH(CH.sub.3)--OR(V),(V) is converted in the presence of magnesium and crotonaldehyde into (VI)H.sub.3 C--CH.dbd.CH--CH(OH)--(CH.sub.2).sub.8 --O--CH(CH.sub.3)--OR(VI)and the protective group R and the hydroxyl group are simultaneously eliminated from (VI) in the presence of acid, novel intermediates for this process, and methods for controlling the codling moth Cydia pomonella by interfering with mating using this mixture are described.Type: GrantFiled: August 7, 1995Date of Patent: February 4, 1997Assignee: BASF AktiengesellschaftInventors: Ulrich Klein, Ulrich Neumann, Wolfgang Mackenroth, Guenter Renz, Wolfgang Krieg, Christiane Mackenroth, Ernst Buschmann, Jacobus J. DeKramer, Roland Milli
-
Patent number: 5585520Abstract: Preparation of O-substituted hydroxylammonium salts IR.sup.1 --CHX--O--NH.sub.2.HL (I)(L=halogen, hydrogensulfate; X=H, alkyl; R.sup.1 =unsubst. or subst. phenyl, thienyl, furanyl, pyrrolyl or --CR.sup.2 .dbd.CR.sup.3 R.sup.4 ; R.sup.2, R.sup.3, R.sup.4 =H, halogen or alkyl) by reaction of an acetone oxime O-allyl or --O--benzyl ether II ##STR1## with water and a mineral acid H--L with continuous removal of the acetone formed in this process, by carrying out the hydrolysis batchwise at 0.degree.-50.degree. C. and under a pressure of 10-500 mbar is described.The O-substituted hydroxylammonium salts I are intermediates for plant protection agents and pharmaceuticals.Type: GrantFiled: January 11, 1996Date of Patent: December 17, 1996Assignee: BASF AktiengesellschaftInventors: Ulrich Klein, Ernst Buschmann, Michael Keil, Norbert G otz, Albrecht Harreus
-
Patent number: 5523485Abstract: A process for preparing high-purity isobutyramide which comprises reacting isobutyryl chloride in toluene or xylene at -15.degree. to 30.degree. C. with ammonia is described.Type: GrantFiled: December 12, 1994Date of Patent: June 4, 1996Assignee: BASF AktiengesellschaftInventors: Lothar Janitschke, Ernst Buschmann
-
Patent number: 5395993Abstract: A process for preparing alkenols of the formula IR.sup.1 --CH.dbd.CH(CH.sub.2).sub.n OH Iwhere R.sup.1 is hydrogen or a hydrocarbon radical, and n is an integer from 3 to 15,a) by reacting a phosphonium salt of the formula IIaR.sup.1 --CH.sub.2 --P.sup.+ (C.sub.6 H.sub.5).sub.3 X.sup.-IIawhere X is chlorine, bromine or iodine, with an aldehyde of the formula IIIa or its hemiacetal of the formula IIIb ##STR1## or b) by reacting a phosphonium salt of the formula IIb(C.sub.6 H.sub.5).sub.3 P.sup.+ (CH.sub.2).sub.n+1 OH X.sup.-IIbwith a aldehyde of the formula IVR.sup.1 CHO IVin a solvent in the presence of a base, wherein the base is the alkali metal salt of an alcohol and the solvent is an alcohol.Type: GrantFiled: February 4, 1994Date of Patent: March 7, 1995Assignee: BASF AktiengesellschaftInventors: Ulrich Klein, Ernst Buschmann, Christiane Mackenroth
-
Patent number: 5382685Abstract: O-substituted hydroxylammonium salts are prepared by hydrolysis of acetone oxime ethers with acid in the presence of an additive, removing acetone and water by distillation with the aid of the additive.Type: GrantFiled: October 5, 1993Date of Patent: January 17, 1995Assignee: BASF AktiengesellschaftInventors: Ulrich Klein, Ernst Buschmann, Michael Keil, Norbert Goetz, Horst Hartmann